ENTRAYNIA Trademark

Trademark Overview

On Monday, October 23, 2017, a trademark application was filed for ENTRAYNIA with the United States Patent and Trademark Office. The USPTO has given the ENTRAYNIA trademark a serial number of 87655887. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 28, 2021. This trademark is owned by Vanda Pharmaceuticals Inc.. The ENTRAYNIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, namely, diseases and disorders related to circadian rhythm; Pharmaceutical preparations for use in the treatment of diseases and disorders having an impact on the central nervous system, namely, diseases and disorders having an impact on circadian rhythm; and Pharmaceutical preparations for use in the treatment of diseases and disorders having a central nervous system manifestation, namely, diseases and disorders manifesting in symptoms related to circadian rhythm
entraynia

General Information

Serial Number87655887
Word MarkENTRAYNIA
Filing DateMonday, October 23, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 27, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, namely, diseases and disorders related to circadian rhythm; Pharmaceutical preparations for use in the treatment of diseases and disorders having an impact on the central nervous system, namely, diseases and disorders having an impact on circadian rhythm; and Pharmaceutical preparations for use in the treatment of diseases and disorders having a central nervous system manifestation, namely, diseases and disorders manifesting in symptoms related to circadian rhythm

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events

Event DateEvent Description
Monday, June 28, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 28, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020EXTENSION 5 GRANTED
Tuesday, November 10, 2020EXTENSION 5 FILED
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 10, 2020TEAS EXTENSION RECEIVED
Thursday, May 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 5, 2020EXTENSION 4 GRANTED
Tuesday, May 5, 2020EXTENSION 4 FILED
Tuesday, May 5, 2020TEAS EXTENSION RECEIVED
Wednesday, May 6, 2020ASSIGNED TO EXAMINER
Saturday, November 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2019EXTENSION 3 GRANTED
Thursday, November 14, 2019EXTENSION 3 FILED
Thursday, November 14, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2019EXTENSION 2 GRANTED
Friday, April 19, 2019EXTENSION 2 FILED
Friday, April 19, 2019TEAS EXTENSION RECEIVED
Tuesday, November 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 9, 2018EXTENSION 1 GRANTED
Friday, November 9, 2018EXTENSION 1 FILED
Friday, November 9, 2018TEAS EXTENSION RECEIVED
Tuesday, May 22, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 16, 2018ASSIGNED TO LIE
Friday, February 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 1, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, February 1, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 1, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, February 1, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, February 1, 2018ASSIGNED TO EXAMINER
Wednesday, November 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 26, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

entraynia disorders diseases pharmaceutical circadian having system rhythm namely nervous treatment